midazolam has been researched along with Colon Cancer, Familial Nonpolyposis in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Vugt van Pinxteren, MW | 1 |
| van Kouwen, MC | 1 |
| van Oijen, MG | 1 |
| van Achterberg, T | 1 |
| Nagengast, FM | 1 |
1 trial available for midazolam and Colon Cancer, Familial Nonpolyposis
| Article | Year |
|---|---|
A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial.
Topics: Adult; Aged; Cathartics; Colonoscopy; Colorectal Neoplasms, Hereditary Nonpolyposis; Female; Heteroz | 2012 |